Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.11.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.11.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.13.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.13.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.32.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.32.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.32.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.32.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.4.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.4.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.86.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.86.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.86.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JG.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used